Search results for "FDA update"
Concentration and dosing of Tamiflu changed
The concentration of oseltamivir phosphate (Tamiflu) oral suspension has been reduced, and labels and dosing have changed accordingly, the FDA announced last week.
https://immattersacp.org/weekly/archives/2011/07/19/8.htm
19 Jul 2011
Linezolid and methylene blue cause problems with psychiatric medications
Linezolid and methylene blue can cause serious reactions in patients who are taking serotonergic psychiatric medications, the FDA warned last week.
https://immattersacp.org/weekly/archives/2011/08/02/7.htm
2 Aug 2011
Daily citalopram dose shouldn't be higher than 40 mg
The antidepressant citalopram hydrobromide (Celexa) should no longer be used at doses greater than 40 mg/d, according to a new warning from the FDA.
https://immattersacp.org/weekly/archives/2011/08/30/7.htm
30 Aug 2011
New dosing for ESAs and oseltamivir, warning on pioglitazone
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/09/fda.htm
1 Sep 2011
Ondansetron contraindicated in patients with QT prolongation
The antinausea drug ondansetron (Zofran) will carry a new warning about the risk of abnormal heart rhythms, the FDA announced last week.
https://immattersacp.org/weekly/archives/2011/09/20/6.htm
20 Sep 2011
New drugs approved for acute coronary syndromes, HIV
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/10/fda.htm
1 Oct 2011
Warnings on Celexa, Zofran; new use of Botox for incontinence
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/11/fda.htm
1 Nov 2011
Deadline this week for rosiglitazone access program
Physicians who want to continue prescribing rosiglitazone-containing medications (Avandia, Avandamet, and Avandaryl) must be enrolled in the Avandia-Rosiglitazone Medicines Access Program by this Thursday, Nov. 17, the FDA reminded last week.
https://immattersacp.org/weekly/archives/2011/11/15/7.htm
15 Nov 2011
Bleeding risk of dabigatran under scrutiny
Serious bleeding events have been reported in patients taking dabigatran (Pradaxa), according to a new FDA MedWatch alert.
https://immattersacp.org/weekly/archives/2011/12/13/7.htm
13 Dec 2011
Polypill gets approval, fenofibric acid gets label change
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/01/fda.htm
1 Jan 2012